Atlas Trials

Madrigal Pharmaceuticals, Inc.

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Madrigal Pharmaceuticals, Inc.

RecordFirmDate
Study of Resmetirom in Children and Adolescents With MASH (NCT07763015)Madrigal Pharmaceuticals, Inc.2026-08-01
Rezdiffra Pregnancy and Lactation Registry (NCT07541469)Madrigal Pharmaceuticals, Inc.2026-03-04
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) (NCT05500222)Madrigal Pharmaceuticals, Inc.2022-08-26
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) (NCT04951219)Madrigal Pharmaceuticals, Inc.2021-07-09
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients (NCT04197479)Madrigal Pharmaceuticals, Inc.2019-12-16
Drug Interaction Study of MGL-3196 With Clopidogrel (NCT04671069)Madrigal Pharmaceuticals, Inc.2019-07-26
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis (NCT03900429)Madrigal Pharmaceuticals, Inc.2019-03-28
Drug Interaction Study of MGL-3196 With Pioglitazone (NCT04671056)Madrigal Pharmaceuticals, Inc.2018-11-09
Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects (NCT04643795)Madrigal Pharmaceuticals, Inc.2018-10-25
Bioavailability Study of MGL-3196 Tablets Compared to Capsules (NCT03413124)Madrigal Pharmaceuticals, Inc.2018-02-05

Track Madrigal Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.